Influenza Vaccine Market: By Type (Inactivated influenza vaccine (IIV) (Quadrivalent and Trivalent) and Live-attenuated influenza vaccine (LAIV)); Process (Egg Based, Cell Culture-Based, and Recombinant); Route of Administration (Injectable and Intra-nasal); Age Group (Pediatric and Adult); Distribution Channel (Hospitals & Pharmacies, Government Suppliers, and Others); Region— Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026–2035
Influenza vaccine market was valued at US$ 10.77 billion in 2025 and is projected to hit the market valuation of US$ 30.77 billion by 2035 at a CAGR of 11.07% during the forecast period 2026–2035. Read More
- Last Updated: 28-Jan-2026 | Format:
![pdf]()
![powerpoint]()
![excel]()
| Report ID: AA0124744
| Report ID: AA0124744Fill out the form below to receive a free sample of this report
Features | Type of License | ||||
 Data Book | Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 1 User Only | Up to 7 Users | Unlimited User Access | |
⨉ | ⨉ | ⨉ | ✓ | ||
Free Customization | No Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ⨉ | ✓ | ✓ | ✓ |
| ✓ | ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ⨉ | ✓ | |
Analyst Support | 2-Months Analyst Support | 4-Months Analyst Support | 7-Months Analyst Support | One Year Analyst Support | |
Free Report update in next update cycle | ⨉ | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ⨉ | ✓ | |
Benefit | Up to 10% off on Post Purchase | Up to 20% off on Post Purchase | Up to 30% off on Post Purchase | Up to 40% off on Post Purchase | |
